EUVIMEDEUVIMED entdecken
Crossref

A Comprehensive Overview of NF1 Mutations in Iranian Patients

Shahram Savad, Mohammad-Hossein Modarressi, Sarang Younesi, Mahnaz Seifi-Alan, Niusha Samadaian, Mona Masoomy, Mehdi Dianatpour, Shima Norouzi, Saloomeh Amidi, Amirreza Boroumand, Mahmoud Reza Ashrafi, Alireza Ronagh und 11 weitere

NeuroMolecular Medicine · 2024

DOI: 10.1007/s12017-024-08790-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2024. Verfasst von Shahram Savad und 22 weiteren Autor:innen. Beteiligte Einrichtung: Genome-Nilou Laboratory, Tehran, Iran. shahram.savad@yahoo.com. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibromin 1, Genes, Neurofibromatosis 1, Exome Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofibromatosis type 1 (NF1) is a genetic disorder caused by mutations in the NF1 gene. This disorder shows nearly complete penetrance and high phenotypic variability. We used the whole-exome sequencing technique to identify mutations in 32 NF1 cases from 22 Iranian families. A total of 31 variants, including 30 point mutations and one large deletion, were detected. In eight cases, variants were inherited, while they were sporadic in the remaining. Seven novel variants, including c.5576 T > G, c.6658_6659insC, c.2322dupT, c.92_93insAA, c.4360C > T, c.3814C > T, and c.4565_4566delinsC, were identified. The current study is the largest in terms of the sample size of Iranian NF1 cases with identified mutations. The results can broaden the spectrum of NF1 mutations and facilitate the process of genetic counseling in the affected families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1Neurofibromin 1Genes, Neurofibromatosis 1Exome SequencingHumansIranFemaleMaleChildPedigreeAdultPoint MutationMutationAdolescentChild, PreschoolYoung AdultDNA Mutational AnalysisSequence Deletion

Stichwörter der Autor:innen

IranMutationNF1

Substanzen

Neurofibromin 1NF1 protein, human

Autor:innen und Institutionen

  • Genome-Nilou Laboratory, Tehran, Iran. shahram.savad@yahoo.com.
  • Genome-Nilou Laboratory, Tehran, Iran.
  • Prenatal Screening Department, Nilou Laboratory, Tehran, Iran.
  • Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Applied Biotechnology Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Zitieren

APA

Savad, S., Modarressi, M. H., Younesi, S., Seifi-Alan, M., Samadaian, N., Masoomy, M., Dianatpour, M., Norouzi, S., Amidi, S., Boroumand, A., Ashrafi, M. R., Ronagh, A., Eslami, M., Hashemnejad, M., Nourian, S., Mohammadi, S., Taheri Amin, M. M., Heidari, M., Seifi-Alan, M., …, & Ghafouri-Fard, S. (2024). A Comprehensive Overview of NF1 Mutations in Iranian Patients. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-024-08790-5

Vancouver

Savad S, Modarressi MH, Younesi S, Seifi-Alan M, Samadaian N, Masoomy M, et al. A Comprehensive Overview of NF1 Mutations in Iranian Patients. NeuroMolecular Medicine. 2024. doi:10.1007/s12017-024-08790-5

BibTeX
@article{Savad2024,
  author = {Savad, Shahram and Modarressi, Mohammad-Hossein and Younesi, Sarang and Seifi-Alan, Mahnaz and Samadaian, Niusha and Masoomy, Mona and Dianatpour, Mehdi and Norouzi, Shima and Amidi, Saloomeh and Boroumand, Amirreza and Ashrafi, Mahmoud Reza and Ronagh, Alireza and Eslami, Maryam and Hashemnejad, Maryam and Nourian, Shahab and Mohammadi, Sanaz and Taheri Amin, Mohammad Mahdi and Heidari, Morteza and Seifi-Alan, Mahin and Shojaaldini Ardakani, Hossein and Aghamahdi, Fatemeh and Khalilian, Sheyda and Ghafouri-Fard, Soudeh},
  title = {A Comprehensive Overview of NF1 Mutations in Iranian Patients},
  journal = {NeuroMolecular Medicine},
  year = {2024},
  doi = {10.1007/s12017-024-08790-5}
}
Kostenlos starten →